Worth Venture Partners »

Aziyo Biologics shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 479k 2.16
2023-09-30 $22k 15k 1.43

More positions owned by Worth Venture Partners

Bloomin Brands Note 5.000% 5/0 (Principal)
Livent Corp Note 4.125% 7/1 (Principal)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Myomo Com New (MYO)
Aspen Aerogels (ASPN)
Chart Inds Note 1.000%11/1 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Scpharmaceuticals (SCPH)
Indie Semiconductor Class A Com (INDI)
Veradigm Note 0.875% 1/0 (Principal)
Transphorm (TGAN)
Transocean Deb 4.625% 9/3 (Principal)
Sarepta Therapeutics DBCV 1.500%11/1 (Principal)
Ouster Com New (OUST)
Geo Corrections Holdings Note 6.500% 2/2 (Principal)

View all positions for Worth Venture Partners

Top funds holding Aziyo Biologics

AIGH Capital Management
Nantahala Capital Management
Alyeska Investment Group
Perkins Capital Management
Worth Venture Partners
Vanguard Group
Indie Asset Partners
Millennium Management
Verdence Capital Advisors
Virtu Financial
Us Bancorp
UBS Group
Royal Bank of Canada
Wells Fargo & Company
Jpmorgan Chase & Co

View all funds holding Aziyo Biologics